CA2852589A1 - Compositions immunomodulatoires et ses utilisations - Google Patents

Compositions immunomodulatoires et ses utilisations Download PDF

Info

Publication number
CA2852589A1
CA2852589A1 CA2852589A CA2852589A CA2852589A1 CA 2852589 A1 CA2852589 A1 CA 2852589A1 CA 2852589 A CA2852589 A CA 2852589A CA 2852589 A CA2852589 A CA 2852589A CA 2852589 A1 CA2852589 A1 CA 2852589A1
Authority
CA
Canada
Prior art keywords
composition
motifs
isolated
polynucleotide
immunosuppressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2852589A
Other languages
English (en)
Inventor
Illimar Altosaar
Tonya Lynn Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA2852589A priority Critical patent/CA2852589A1/fr
Publication of CA2852589A1 publication Critical patent/CA2852589A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206—Colostrum; Human milk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/17—Immunomodulatory nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/10—Production naturally occurring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pediatric Medicine (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2852589A 2014-05-26 2014-05-26 Compositions immunomodulatoires et ses utilisations Abandoned CA2852589A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2852589A CA2852589A1 (fr) 2014-05-26 2014-05-26 Compositions immunomodulatoires et ses utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2852589A CA2852589A1 (fr) 2014-05-26 2014-05-26 Compositions immunomodulatoires et ses utilisations

Publications (1)

Publication Number Publication Date
CA2852589A1 true CA2852589A1 (fr) 2015-11-26

Family

ID=54704504

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2852589A Abandoned CA2852589A1 (fr) 2014-05-26 2014-05-26 Compositions immunomodulatoires et ses utilisations

Country Status (1)

Country Link
CA (1) CA2852589A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022182814A1 (fr) * 2021-02-24 2022-09-01 Milk Care Co., Inc. Préparations pour nourrissons contenant des protéines de lait maternel humain

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022182814A1 (fr) * 2021-02-24 2022-09-01 Milk Care Co., Inc. Préparations pour nourrissons contenant des protéines de lait maternel humain

Similar Documents

Publication Publication Date Title
Ward et al. Human milk metagenome: a functional capacity analysis
US10583158B2 (en) Compositions comprising bacterial strains
US10610549B2 (en) Composition comprising bacterial strains
AU2017374767B2 (en) Compositions comprising bacterial strains
ES2660813T3 (es) Nueva bacteria de ácido láctico, fármaco, producto alimenticio o bebida, y pienso que contienen la nueva bacteria de ácido láctico
EP4125441B1 (fr) Composition comprenant akkermansia dsm 33459 pour améliorer la santé métabolique
KR102794442B1 (ko) 신규한 프로바이오틱스 비피도박테리움 균주
CA2973223A1 (fr) Compositions probiotiques et prebiotiques, et leurs procedes d'utilisation pour la modulation du microbiome
TWI594758B (zh) 包含雙歧桿菌的組合物、其製備方法及其用途
CN106604736B (zh) 副干酪乳杆菌促进生态失调后肠道菌群多样性恢复的应用
CN111212575A (zh) 肌肉增量用组合物
US20200316023A1 (en) Method Of Producing Bacterially Derived Indole-3-Propionic Acid And Compositions Comprising Same
US20110158951A1 (en) Use of blood group status ii
Gill Lactic acid bacteria as probiotics: Current status and future prospects
TW202027767A (zh) 包含細菌菌株之組合物
US20110158950A1 (en) Use of blood group status i
CA2852589A1 (fr) Compositions immunomodulatoires et ses utilisations
US11224620B2 (en) Compositions comprising bacterial strains
JP2020132560A (ja) 糖吸収促進用組成物
BG112471A (bg) Имуномодулиращ синбиотичен състав
Cano et al. Demonstration of the cellular viability and safety of Enterococcus faecium CRL 183 in long-term experiments
CA3046705C (fr) Nouvelles souches de bifidobacteries probiotiques
WO2026062250A2 (fr) Compositions probiotiques et leurs utilisations
WO2023120547A1 (fr) Composition pour prévenir des maladies sexuellement transmissibles secondaires ou réduire le risque de développer celles-ci
Hassan Use Of Mushroom Extract To Enhance Quality And Health Benefits Of Dairy Products

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20170526